{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:45:51Z","timestamp":1789836351778,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jiac.2023.09.010","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:12:04Z","timestamp":1694751124000},"page":"34-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["In vivo efficacy and PK\/PD analyses of zifanocycline (KBP-7072), an aminomethylcycline antibiotic, against Acinetobacter baumannii in a neutropenic murine thigh infection model"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1016-5816","authenticated-orcid":false,"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanju","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4389-4901","authenticated-orcid":false,"given":"Jay","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2023.09.010_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2023.09.010_bib2","series-title":"Antibiotic resistance threats in the United States, 2019","year":"2019"},{"key":"10.1016\/j.jiac.2023.09.010_bib3","series-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","year":"2017"},{"key":"10.1016\/j.jiac.2023.09.010_bib4","first-page":"491","article-title":"Emergence of antimicrobial resistance among Acinetobacter species: a global threat","volume":"22","author":"Clark","year":"2016","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jiac.2023.09.010_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jhm.2477","article-title":"Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: a survey study","volume":"11","author":"Zilberberg","year":"2016","journal-title":"J Hosp Med"},{"key":"10.1016\/j.jiac.2023.09.010_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/ofid\/ofx176","article-title":"Prevalence of carbapenem-resistant Gram-negative infections in the United States predominated by Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"4","author":"Cai","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2023.09.010_bib7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/1469-0691.12363","article-title":"Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis","volume":"20","author":"Lemos","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2023.09.010_bib8","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Disease Society of America guidance on the treatment of AmpC beta-lactamase-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.09.010_bib9","doi-asserted-by":"crossref","first-page":"dlab177","DOI":"10.1093\/jacamr\/dlab177","article-title":"In vitro activity of a novel aminomethylcycline antibacterial (KBP-7072), a third-generation tetracycline, against clinical isolates with molecularly characterized tetracycline resistance mechanisms","volume":"3","author":"Pfaller","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.jiac.2023.09.010_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01397-21","article-title":"Activity of the novel aminomethylcycline KBP-7072 and comparators against 1,057 geographically diverse recent clinical isolates from the SENTRY Surveillance Program, 2019","volume":"66","author":"Huband","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.09.010_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01471-21","article-title":"In vitro activity of KBP-7072 against 536 Acinetobacter baumannii Complex isolates collected in China","volume":"10","author":"Han","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiac.2023.09.010_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02375-19","article-title":"In vitro activity of KBP-7072, a novel third-generation tetracycline, against 531 recent geographically diverse and molecularly characterized Acinetobacter baumannii species Complex isolates","volume":"64","author":"Huband","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.09.010_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02404-18","article-title":"Pharmacokinetic\/pharmacodynamic evaluation of a novel aminomethylcycline antibiotic, KBP-7072, in the neutropenic murine pneumonia model against Staphylococcus aureus and Streptococcus pneumoniae","volume":"63","author":"Lepak","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.09.010_bib14","article-title":"In vivo efficacy and PK\/PD modeling of KBP-7072, an aminomethylcycline antibiotic, in neutropenic pneumonia and thigh infection models","author":"Tan","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jiac.2023.09.010_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00488-20","article-title":"Nonclinical pharmacokinetics, protein binding, and elimination of KBP-7072, an aminomethylcycline antibiotic, in animal models","volume":"64","author":"Tan","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.09.010_bib16","series-title":"CLSI document M07-A10","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-tenth edition","year":"2015"},{"key":"10.1016\/j.jiac.2023.09.010_bib17","series-title":"CLSI document M100S","article-title":"Performance standards for antimicrobial susceptibility testing; twenty-sixth informational supplement","year":"2016"},{"key":"10.1016\/j.jiac.2023.09.010_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2023.09.010_bib19","first-page":"1169","article-title":"Magnitude of the 24-h AUC\/MIC required for efficacy of doxycycline (DOXY) against Streptococcus pneumoniae (SP) in a murine thigh-infection model","volume":"33","author":"Christianson","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.09.010_bib20","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/AAC.00647-08","article-title":"Pharmacodynamics of tigecycline against phenotypically diverse Staphylococcus aureus isolates in a murine thigh model","volume":"53","author":"Crandon","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.09.010_bib21","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/AAC.00985-09","article-title":"Pharmacodynamic profile of tigecycline against methicillin-resistant Staphylococcus aureus in an experimental pneumonia model","volume":"53","author":"Koomanachai","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.09.010_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02368-16","article-title":"In vivo pharmacodynamic evaluation of omadacycline (PTK 0796) against Streptococcus pneumoniae in the murine pneumonia model","volume":"61","author":"Lepak","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.09.010_bib23","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1128\/AAC.01678-08","article-title":"In vivo pharmacodynamic profile of tigecycline against phenotypically diverse Escherichia coli and Klebsiella pneumoniae isolates","volume":"53","author":"Nicasio","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.09.010_bib24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1128\/AAC.44.4.943-949.2000","article-title":"In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram negative bacteria","volume":"44","author":"van Ogtrop","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.09.010_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00250-17","article-title":"In vivo pharmacodynamic target assessment of eravacycline against Escherichia coli in a murine thigh infection model","volume":"61","author":"Zhao","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.09.010_bib26","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s40121-021-00541-4","article-title":"Contemporary perspective on the treatment of Acinetobacter baumannii infections: insights from the society of infectious Diseases Pharmacists","volume":"10","author":"Abdul-Mutakabbir","year":"2021","journal-title":"Infect Dis Ther"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23002155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23002155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:06:41Z","timestamp":1761160001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X23002155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1341321X23002155"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2023.09.010","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo efficacy and PK\/PD analyses of zifanocycline (KBP-7072), an aminomethylcycline antibiotic, against Acinetobacter baumannii in a neutropenic murine thigh infection model","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2023.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}